Clinical Trials Initial Budgets for Patient Recruitment: Phases of Study
- Author Lydia Daisy
- Published November 27, 2012
- Word count 506
Patient optimization, recruitment and retention, a key determinant of the success of a clinical trial, has always been a challenge. It is becoming more challenging with the increased complexity of clinical trial design, stringent eligibility criteria and the trend toward more targeted patient population. Considering importance of patient recruitment & retention in clinical trials to achieve the business objective but surprisingly, many companies do not dedicate any funds to this activity in the initial budgeting process. In fact, many companies do not plan for patient recruitment at all, believing that patient recruitment will happen some companies invest a lump sum to CROs, SMOs or sites and rely on them to recruit patients.
Pharmaceutical companies know that quick enrollment is essential. To aid in the process, some companies employ patient recruitment companies. Others design creative campaigns specifically aimed at the patient set needed for their trials. Whatever their efforts, the companies that support their site's efforts with good recruitment campaigns, fueled by appropriate budgets, and more success in trial recruitment. This level of support is important because, after all, trial delays lead to product-launch delays which cost money in the long run.
This article en lights on average estimated costs spent by the pharmaceutical companies for patient recruitment for clinical trials from phase I to Phase IV.
Patient Recruitment Budgets
The recruitment pattern for Phase 1 trials is different as well. One Phase 1 patient enrolled is equal to 10 to 20 Phase 3 patients enrolled. This is partly because of the complications that come along with recruiting patients for Phase 1 trials. After all, the primary goals of Phase 1 trials do not include therapeutic benefit and most often require healthy patients. For Phase 3 studies, doctors will bring in patients one at a time, but for a Phase 1 study, they'll bring in 30 at a time because it's not cost-feasible to do one at a time. In phase 1 overall initial budget dedicated for patient recruitment is 0% and 15%, site budget is $10,000 and $800,000 and patient budget is $2,108.
As companies enter Phase 2 trials, the number of patients required increases, raising the stakes in terms of patient recruitment that overall trial budgets increase for sponsor companies/CROs as well. Along with increases in budgets from Phase 1, the percentage of budgets dedicated to patient recruitment also increases. In phase 2 overall initial budget dedicated for patient recruitment is 50%, site budget is $5,000 to $90,000 and patient budget is $52.
Phase 3 trials generally require a much larger number of patients than either Phase 1 or 2 trials. As such, it is not surprising that overall trial budgets increase significantly over the previous two phases. In phase 3a overall initial budget dedicated for patient recruitment is 50%, site budget is $5,000 to $90,000 and patient budget is $60 and $250. For phase 3b overall initial budget dedicated for patient recruitment is 6% to 20%, site budget is Higher percentage of their budgets to patient recruitment than 3a and patient budget is in line with that of Phase 3a.
Phase 4 trials can vary fairly widely in size and scope. For Phase 4 trial overall initial budget dedicated for patient recruitment is 53%, site budget $1,200 and patient budget is $736.
This article is written by an employee of MakroCare, explaining the budgets spent for patent recruitment from Phase I to Phase IV. MakroCare, established in 1996, is an international Drug Development and Commercialization services firm that is dedicated to support Life Sciences industry.
Article source: https://articlebiz.comRate article
Article comments
There are no posted comments.
Related articles
- Fighting the Silent Epidemic: Safeguard Your Child's Future with Vitamin D Screening at KinderCure | Dr. Garima Mengi
- Enhancing Child Health with Mindfulness: Insights from KinderCure’s Dr. Garima Mengi
- Advanced Rolfing Fort Worth Dallas Is The New #1 Paradigm Pain Manager
- Advanced Rolfing Fort Worth - Endogenous Pain Management
- Advanced Rolfing Fort Worth - Treatment Six
- Advanced Rolfing Fort Worth- Treatment 5
- Post-COVID Booster Breastfeeding: Essential for Transferring Protective Antibodies to Babies, Bolstering Infant Health
- Humeral shaft fractures: Clinical picture, diagnosis, treatment.
- How Much Stress Is Too Much Stress? The Ayurvedic Perspective
- A New Era of Personalized Healthcare
- Staying Safe with Medications at Home
- Overmedicating Youth in Care: Change is Needed
- Evolution of Healing: Uncovering the Secrets of the Body from Shamanism to Modern Anatomy
- Home Health Care in North Bellmore
- Unlocking Healthier Futures: Iron Nutrition for Children at KinderCure
- The Dangers of Drug and Alcohol Detox
- Top 7 Latest List of Medical Billing Companies in the USA
- Managing Lactose Intolerance in Children: Expert Guide by KinderCure
- Research-Based Medical Thesis Are Becoming More Important in Chicago to Advance Healthcare
- Revolutionizing Medicine: Breakthroughs in Innovative Diagnostic Technologies
- Childhood Anxiety: Navigating Challenges with KinderCure's Expert Guidance
- Strengthening Your Child’s Immunity Naturally: Proven Tips from KinderCure Clinic
- Colic in Babies: Essential Guide for Parents by Experts at KinderCure
- Playtime Revolution: KinderCure's Guide to Boosting Child Development Through Play
- Colic Relief for Infants: Expert Parenting Tips from KinderCure Clinic, Gurgaon
- Combating Childhood Obesity in India: Strategies and Success Stories from KinderCure Clinic, Gurgaon
- Understanding the Importance of Early Childhood Nutrition: Insights from KinderCure
- Diaper Rash: Prevention, Treatment, and When to See a Doctor
- Chiropractic Treatment for Neck Pain and Nerve Pain Syndromes
- Revolutionizing Healthcare: The Personalized Power of Precision Medicine